Devin W. Steenkamp, MBChB

Assistant Professor, Medicine

Devin Steenkamp
617.414.2938
732 Harrison Ave

Biography

Devin Steenkamp is a clinician investigator focusing his academic work and research efforts on various projects that have translational impact in understanding the pathophysiological underpinnings of atypical diabetes phenotypes with a focus on type 1 diabetes and monogenic diabetes. He has a particular interest in understanding proinsulin physiology in long standing type 1 diabetes. In addition, he is the principal investigator on a variety of clinical trials related to diabetes pharmacotherapy and the application of novel diabetes technologies. He is the Director of the Clinical Diabetes Program at Boston Medical Center and his clinical practice is focused on the use of diabetes technologies in clinical care.

Education

  • University of Pretoria, MBChB

Publications

  • Published on 6/1/2019

    Steenkamp D. CONTINUOUS GLUCOSE MONITORING AS A HYPOGLYCEMIA MITIGATION TOOL IN INDIVIDUALS WITH TYPE 1 DIABETES WITH IMPAIRED HYPOGLYCEMIC AWARENESS. Endocr Pract. 2019 Jun; 25(6):619-621. PMID: 31242124.

    Read at: PubMed
  • Published on 5/1/2019

    Steenkamp DW, Cacicedo JM, Sullivan CA. Comment on Sims et al. Proinsulin Secretion Is a Persistent Feature of Type 1 Diabetes. Diabetes Care 2019;42:258-264. Diabetes Care. 2019 May; 42(5):e84. PMID: 31010951.

    Read at: PubMed
  • Published on 5/1/2019

    Stockman MC, Modzelewski K, Steenkamp D. Mobile Health and Technology Usage by Patients in the Diabetes, Nutrition, and Weight Management Clinic at an Urban Academic Medical Center. Diabetes Technol Ther. 2019 Jul; 21(7):400-405. PMID: 31045447.

    Read at: PubMed
  • Published on 1/13/2019

    Fantasia K, Modzelewski K, Steenkamp D. Predictive Glucose Trends From Continuous Glucose Monitoring: Friend or Foe in Clinical Decision Making? J Diabetes Sci Technol. 2019 Sep; 13(5):963-966. PMID: 30636438.

    Read at: PubMed
  • Published on 11/9/2018

    Sullivan CA, Cacicedo JM, Rajendran I, Steenkamp DW. Comparison of proinsulin and C-peptide secretion in healthy versus long-standing type 1 diabetes mellitus cohorts: A pilot study. PLoS One. 2018; 13(11):e0207065. PMID: 30412637.

    Read at: PubMed
  • Published on 6/29/2018

    Rodriguez-Diaz E, Rizo I, Sullivan C, Steenkamp DW. Perioperative Use of a Hybrid Closed Loop System in an Obese Patient With Type 1 Diabetes Undergoing Metabolic Surgery: Insights Into Changes in Insulin Delivery and Sensitivity. J Diabetes Sci Technol. 2018 11; 12(6):1239-1240. PMID: 29957042.

    Read at: PubMed
  • Published on 12/4/2017

    Jones Iv AR, Coleman EL, Husni NR, Deeney JT, Raval F, Steenkamp D, Dooms H, Nikolajczyk BS, Corkey BE. Type 1 diabetes alters lipid handling and metabolism in human fibroblasts and peripheral blood mononuclear cells. PLoS One. 2017; 12(12):e0188474. PMID: 29206239.

    Read at: PubMed
  • Published on 11/16/2017

    Steenkamp DW, Cacicedo JM, Sahin-Efe A, Sullivan C, Sternthal E. PRESERVED PROINSULIN SECRETION IN LONG-STANDING TYPE 1 DIABETES. Endocr Pract. 2017 Dec; 23(12):1387-1393. PMID: 29144809.

    Read at: PubMed
  • Published on 9/27/2017

    Modzelewski KL, Stockman MC, Steenkamp DW. Rethinking the Endpoints of mHealth Intervention Research in Diabetes Care. J Diabetes Sci Technol. 2018 03; 12(2):389-392. PMID: 28952379.

    Read at: PubMed
  • Published on 6/23/2017

    Herron A, Sullivan C, Brouillard E, Steenkamp D. Late to the Party: Importance of Dietary Fat and Protein in the Intensive Management of Type 1 Diabetes. A Case Report. J Endocr Soc. 2017 Aug 01; 1(8):1002-1005. PMID: 29264550.

    Read at: PubMed

View 21 more publications: View full profile at BUMC

View all profiles